INM Competitors & Alternatives

Compare InMed Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

INM

Main Stock
$1.56
Tradestie Score
55
Market Cap
$5.29M
Revenue Growth
-0.3%
Analyst Upside
+1182.1%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.18
$711.32M - 54 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 59 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.50
$543.32M - 57 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.33
$237.15M 6.6 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$25.10
$212.23M - 55 Compare
PALI Palisade Bio, Inc. Common Stock
$2.10
$12.21M 16.4 52 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.28
$7.21M - 54 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$4.58
$4.25M - 52 Compare
REVB Revelation Biosciences, Inc. Common Stock
$1.08
$3.42M - 49 Compare
NUWE Nuwellis, Inc. Common Stock
$3.15
$2.90M - 48 Compare

Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry